FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994085514> ?p ?o ?g. }

• W1994085514 endingPage "415" @default.
• W1994085514 startingPage "408" @default.
• W1994085514 abstract "In 2002, 1329 patients with functioning transplants were prospectively tested for HLA antibodies in the 13th International Histocompatibility Workshop. Four years after testing, deceased donor graft survival among 806 patients not having antibodies in 2002 was 81% compared to 58% for 158 patients with HLA antibodies (p < 0.0001) and 72% for 69 patients with MICA antibodies (p = 0.02). Hazard ratio (HR) using death-censored graft survival from multivariate analysis of HLA antibodies was 3.3 (p < 0.00001) and 2.04 for MICA (p = 0.01).In the 14th Workshop, at 1 year follow-up, survival for 1319 patients receiving deceased donor grafts and no HLA antibodies was 96% compared to 94% for 344 patients with HLA antibodies (p = 0.0004) and 83% survival for 33 patients with MICA (p = 0.0005). HR from multivariate analysis: HLA antibodies was 3.6 (p < 0.00001) and 6.1 for MICA (p = 0.006). Twelve patients with donor specific antibodies tested by single antigen beads had a 1 year survival of 64% (p = 0.008), and 27 patients with non-donor specific ‘strong’ antibodies had a 66% survival (p = 0.0003) compared to 92% survival in those with no antibodies.In conclusion, these two prospective trials, after 1 and 4 years, provided strong evidence that HLA and MICA antibodies are associated with graft failure. In 2002, 1329 patients with functioning transplants were prospectively tested for HLA antibodies in the 13th International Histocompatibility Workshop. Four years after testing, deceased donor graft survival among 806 patients not having antibodies in 2002 was 81% compared to 58% for 158 patients with HLA antibodies (p < 0.0001) and 72% for 69 patients with MICA antibodies (p = 0.02). Hazard ratio (HR) using death-censored graft survival from multivariate analysis of HLA antibodies was 3.3 (p < 0.00001) and 2.04 for MICA (p = 0.01). In the 14th Workshop, at 1 year follow-up, survival for 1319 patients receiving deceased donor grafts and no HLA antibodies was 96% compared to 94% for 344 patients with HLA antibodies (p = 0.0004) and 83% survival for 33 patients with MICA (p = 0.0005). HR from multivariate analysis: HLA antibodies was 3.6 (p < 0.00001) and 6.1 for MICA (p = 0.006). Twelve patients with donor specific antibodies tested by single antigen beads had a 1 year survival of 64% (p = 0.008), and 27 patients with non-donor specific ‘strong’ antibodies had a 66% survival (p = 0.0003) compared to 92% survival in those with no antibodies. In conclusion, these two prospective trials, after 1 and 4 years, provided strong evidence that HLA and MICA antibodies are associated with graft failure." @default.
• W1994085514 created "2016-06-24" @default.
• W1994085514 creator A5031568129 @default.
• W1994085514 creator A5056024478 @default.
• W1994085514 creator A5085541039 @default.
• W1994085514 date "2007-02-01" @default.
• W1994085514 modified "2023-10-18" @default.
• W1994085514 title "Four-year Follow-up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival" @default.
• W1994085514 cites W1560633215 @default.
• W1994085514 cites W1964209790 @default.
• W1994085514 cites W1969515571 @default.
• W1994085514 cites W1970782883 @default.
• W1994085514 cites W1994067417 @default.
• W1994085514 cites W2000070744 @default.
• W1994085514 cites W2004953390 @default.
• W1994085514 cites W2005439779 @default.
• W1994085514 cites W2015314901 @default.
• W1994085514 cites W2024742663 @default.
• W1994085514 cites W2041198668 @default.
• W1994085514 cites W2041331235 @default.
• W1994085514 cites W2053112518 @default.
• W1994085514 cites W2065042783 @default.
• W1994085514 cites W2070076886 @default.
• W1994085514 cites W2070159616 @default.
• W1994085514 cites W2076405972 @default.
• W1994085514 cites W2092409392 @default.
• W1994085514 cites W2097293181 @default.
• W1994085514 cites W2149358482 @default.
• W1994085514 cites W2153266666 @default.
• W1994085514 cites W2167779256 @default.
• W1994085514 doi "https://doi.org/10.1111/j.1600-6143.2006.01644.x" @default.
• W1994085514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17229080" @default.
• W1994085514 hasPublicationYear "2007" @default.
• W1994085514 type Work @default.
• W1994085514 sameAs 1994085514 @default.
• W1994085514 citedByCount "330" @default.
• W1994085514 countsByYear W19940855142012 @default.
• W1994085514 countsByYear W19940855142013 @default.
• W1994085514 countsByYear W19940855142014 @default.
• W1994085514 countsByYear W19940855142015 @default.
• W1994085514 countsByYear W19940855142016 @default.
• W1994085514 countsByYear W19940855142017 @default.
• W1994085514 countsByYear W19940855142018 @default.
• W1994085514 countsByYear W19940855142019 @default.
• W1994085514 countsByYear W19940855142020 @default.
• W1994085514 countsByYear W19940855142021 @default.
• W1994085514 countsByYear W19940855142022 @default.
• W1994085514 countsByYear W19940855142023 @default.
• W1994085514 crossrefType "journal-article" @default.
• W1994085514 hasAuthorship W1994085514A5031568129 @default.
• W1994085514 hasAuthorship W1994085514A5056024478 @default.
• W1994085514 hasAuthorship W1994085514A5085541039 @default.
• W1994085514 hasBestOaLocation W19940855141 @default.
• W1994085514 hasConcept C126322002 @default.
• W1994085514 hasConcept C141071460 @default.
• W1994085514 hasConcept C147483822 @default.
• W1994085514 hasConcept C159654299 @default.
• W1994085514 hasConcept C188280979 @default.
• W1994085514 hasConcept C188816634 @default.
• W1994085514 hasConcept C202965653 @default.
• W1994085514 hasConcept C203014093 @default.
• W1994085514 hasConcept C207103383 @default.
• W1994085514 hasConcept C44249647 @default.
• W1994085514 hasConcept C71924100 @default.
• W1994085514 hasConcept C90924648 @default.
• W1994085514 hasConceptScore W1994085514C126322002 @default.
• W1994085514 hasConceptScore W1994085514C141071460 @default.
• W1994085514 hasConceptScore W1994085514C147483822 @default.
• W1994085514 hasConceptScore W1994085514C159654299 @default.
• W1994085514 hasConceptScore W1994085514C188280979 @default.
• W1994085514 hasConceptScore W1994085514C188816634 @default.
• W1994085514 hasConceptScore W1994085514C202965653 @default.
• W1994085514 hasConceptScore W1994085514C203014093 @default.
• W1994085514 hasConceptScore W1994085514C207103383 @default.
• W1994085514 hasConceptScore W1994085514C44249647 @default.
• W1994085514 hasConceptScore W1994085514C71924100 @default.
• W1994085514 hasConceptScore W1994085514C90924648 @default.
• W1994085514 hasIssue "2" @default.
• W1994085514 hasLocation W19940855141 @default.
• W1994085514 hasLocation W19940855142 @default.
• W1994085514 hasOpenAccess W1994085514 @default.
• W1994085514 hasPrimaryLocation W19940855141 @default.
• W1994085514 hasRelatedWork W1615700017 @default.
• W1994085514 hasRelatedWork W1969366085 @default.
• W1994085514 hasRelatedWork W1977392131 @default.
• W1994085514 hasRelatedWork W2040191638 @default.
• W1994085514 hasRelatedWork W2108167995 @default.
• W1994085514 hasRelatedWork W2120418867 @default.
• W1994085514 hasRelatedWork W2444310449 @default.
• W1994085514 hasRelatedWork W3086952685 @default.
• W1994085514 hasRelatedWork W4252712041 @default.
• W1994085514 hasRelatedWork W4313351422 @default.
• W1994085514 hasVolume "7" @default.
• W1994085514 isParatext "false" @default.
• W1994085514 isRetracted "false" @default.
• W1994085514 magId "1994085514" @default.
• W1994085514 workType "article" @default.